Report Cover

Global Adalimumab Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026


The Adalimumab market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Adalimumab size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Adalimumab market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Adalimumab market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Adalimumab
    Adalimumab Biosimilar

Market segment by Application can be divided into
    Adults
    Children

The key market players for global Adalimumab market are listed below:
    AbbVie
    Amgen
    Sandoz
    Boehringer Ingelheim
    Mylan
    Biogen

Market segment by Region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
    1.1 Adalimumab Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Adalimumab Revenue by Type: 2019 Versus 2021 Versus 2026
        1.2.2 Adalimumab
        1.2.3 Adalimumab Biosimilar
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Adalimumab Revenue by Application: 2019 Versus 2021 Versus 2026
        1.3.2 Adults
        1.3.3 Children
    1.4 Global Adalimumab Market Size & Forecast
        1.4.1 Global Adalimumab Sales in Value (2016-2026))
        1.4.2 Global Adalimumab Sales in Volume (2016-2026)
        1.4.3 Global Adalimumab Price by Type (2016-2026) & (USD/Unit)
    1.5 Global Adalimumab Production Capacity Analysis
        1.5.1 Global Adalimumab Total Production Capacity (2016-2026)
        1.5.2 Global Adalimumab Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Adalimumab Market Drivers
        1.6.2 Adalimumab Market Restraints
        1.6.3 Adalimumab Trends Analysis
2 Manufacturers Profiles
    2.1 AbbVie
        2.1.1 AbbVie Details
        2.1.2 AbbVie Major Business
        2.1.3 AbbVie Adalimumab Product and Services
        2.1.4 AbbVie Adalimumab Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.2 Amgen
        2.2.1 Amgen Details
        2.2.2 Amgen Major Business
        2.2.3 Amgen Adalimumab Product and Services
        2.2.4 Amgen Adalimumab Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.3 Sandoz
        2.3.1 Sandoz Details
        2.3.2 Sandoz Major Business
        2.3.3 Sandoz Adalimumab Product and Services
        2.3.4 Sandoz Adalimumab Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.4 Boehringer Ingelheim
        2.4.1 Boehringer Ingelheim Details
        2.4.2 Boehringer Ingelheim Major Business
        2.4.3 Boehringer Ingelheim Adalimumab Product and Services
        2.4.4 Boehringer Ingelheim Adalimumab Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.5 Mylan
        2.5.1 Mylan Details
        2.5.2 Mylan Major Business
        2.5.3 Mylan Adalimumab Product and Services
        2.5.4 Mylan Adalimumab Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
    2.6 Biogen
        2.6.1 Biogen Details
        2.6.2 Biogen Major Business
        2.6.3 Biogen Adalimumab Product and Services
        2.6.4 Biogen Adalimumab Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Adalimumab Sales by Manufacturer
    3.1 Global Adalimumab Sales in Volume by Manufacturer (2019-2021e)
    3.2 Global Adalimumab Revenue by Manufacturer (2019-2021e)
    3.3 Key Manufacturer Market Position in Adalimumab
    3.4 Market Concentration Rate
        3.4.1 Top 3 Adalimumab Manufacturer Market Share
        3.4.2 Top 6 Adalimumab Manufacturer Market Share
    3.5 Global Adalimumab Production Capacity by Company
    3.6 Manufacturer by Geography: Head Office and Adalimumab Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions
4 Market Analysis by Region
    4.1 Global Adalimumab Market Size by Region
        4.1.1 Global Adalimumab Sales in Volume by Region (2016-2026)
        4.1.2 Global Adalimumab Revenue by Region (2016-2026)
    4.2 North America Adalimumab Revenue (2016-2026)
    4.3 Europe Adalimumab Revenue (2016-2026)
    4.4 Asia-Pacific Adalimumab Revenue (2016-2026)
    4.5 South America Adalimumab Revenue (2016-2026)
    4.6 Middle East and Africa Adalimumab Revenue (2016-2026)
5 Market Segment by Type
    5.1 Global Adalimumab Sales in Volume by Type (2016-2026)
    5.2 Global Adalimumab Revenue by Type (2016-2026)
    5.3 Global Adalimumab Price by Type (2016-2026)
6 Market Segment by Application
    6.1 Global Adalimumab Sales in Volume by Application (2016-2026)
    6.2 Global Adalimumab Revenue by Application (2016-2026)
    6.3 Global Adalimumab Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
    7.1 North America Adalimumab Sales by Type (2016-2026)
    7.2 North America Adalimumab Sales by Application (2016-2026)
    7.3 North America Adalimumab Market Size by Country
        7.3.1 North America Adalimumab Sales in Volume by Country (2016-2026)
        7.3.2 North America Adalimumab Revenue by Country (2016-2026)
        7.3.3 United States Market Size and Forecast (2016-2026)
        7.3.4 Canada Market Size and Forecast (2016-2026)
        7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
    8.1 Europe Adalimumab Sales by Type (2016-2026)
    8.2 Europe Adalimumab Sales by Application (2016-2026)
    8.3 Europe Adalimumab Market Size by Country
        8.3.1 Europe Adalimumab Sales in Volume by Country (2016-2026)
        8.3.2 Europe Adalimumab Revenue by Country (2016-2026)
        8.3.3 Germany Market Size and Forecast (2016-2026)
        8.3.4 France Market Size and Forecast (2016-2026)
        8.3.5 United Kingdom Market Size and Forecast (2016-2026)
        8.3.6 Russia Market Size and Forecast (2016-2026)
        8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
    9.1 Asia-Pacific Adalimumab Sales by Type (2016-2026)
    9.2 Asia-Pacific Adalimumab Sales by Application (2016-2026)
    9.3 Asia-Pacific Adalimumab Market Size by Region
        9.3.1 Asia-Pacific Adalimumab Sales in Volume by Region (2016-2026)
        9.3.2 Asia-Pacific Adalimumab Revenue by Region (2016-2026)
        9.3.3 China Market Size and Forecast (2016-2026)
        9.3.4 Japan Market Size and Forecast (2016-2026)
        9.3.5 Korea Market Size and Forecast (2016-2026)
        9.3.6 India Market Size and Forecast (2016-2026)
        9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
        9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
    10.1 South America Adalimumab Sales by Type (2016-2026)
    10.2 South America Adalimumab Sales by Application (2016-2026)
    10.3 South America Adalimumab Market Size by Country
        10.3.1 South America Adalimumab Sales in Volume by Country (2016-2026)
        10.3.2 South America Adalimumab Revenue by Country (2016-2026)
        10.3.3 Brazil Market Size and Forecast (2016-2026)
        10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Adalimumab Sales by Type (2016-2026)
    11.2 Middle East & Africa Adalimumab Sales by Application (2016-2026)
    11.3 Middle East & Africa Adalimumab Market Size by Country
        11.3.1 Middle East & Africa Adalimumab Sales in Volume by Country (2016-2026)
        11.3.2 Middle East & Africa Adalimumab Revenue by Country (2016-2026)
        11.3.3 Turkey Market Size and Forecast (2016-2026)
        11.3.4 Egypt Market Size and Forecast (2016-2026)
        11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
        11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
    12.1 Sales Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
    12.2 Adalimumab Typical Distributors
    12.3 Adalimumab Typical Customers
13 Research Findings and Conclusion
14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

List of Tables Table 1. Global Adalimumab Revenue by Type, (USD Million), 2021-2026 Table 2. Global Adalimumab Revenue by Application, (USD Million), 2021-2026 Table 3. AbbVie Basic Information, Manufacturing Base and Competitors Table 4. AbbVie Major Business Table 5. AbbVie Adalimumab Product and Services Table 6. AbbVie Adalimumab Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 7. Amgen Basic Information, Manufacturing Base and Competitors Table 8. Amgen Major Business Table 9. Amgen Adalimumab Product and Services Table 10. Amgen Adalimumab Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 11. Sandoz Basic Information, Manufacturing Base and Competitors Table 12. Sandoz Major Business Table 13. Sandoz Adalimumab Product and Services Table 14. Sandoz Adalimumab Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 15. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors Table 16. Boehringer Ingelheim Major Business Table 17. Boehringer Ingelheim Adalimumab Product and Services Table 18. Boehringer Ingelheim Adalimumab Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 19. Mylan Basic Information, Manufacturing Base and Competitors Table 20. Mylan Major Business Table 21. Mylan Adalimumab Product and Services Table 22. Mylan Adalimumab Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 23. Biogen Basic Information, Manufacturing Base and Competitors Table 24. Biogen Major Business Table 25. Biogen Adalimumab Product and Services Table 26. Biogen Adalimumab Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 27. Global Adalimumab Sales by Manufacturer (2019-2021e) & (K Units) Table 28. Global Adalimumab Revenue by Manufacturer (2019-2021e) & (USD Million) Table 29. Market Position of Manufacturers in Adalimumab, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020 Table 30. Global Adalimumab Production Capacity by Company, (K Units): 2020 VS 2021 Table 31. Head Office and Adalimumab Production Site of Key Manufacturer Table 32. Global Adalimumab Sales by Region (2016-2021e) & (K Units) Table 33. Global Adalimumab Sales by Region (2021-2026) & (K Units) Table 34. Global Adalimumab Revenue by Region (2016-2021e) & (USD Million) Table 35. Global Adalimumab Revenue by Region (2021-2026) & (USD Million) Table 36. Global Adalimumab Sales by Type (2016-2021e) & (K Units) Table 37. Global Adalimumab Sales by Type (2021-2026) & (K Units) Table 38. Global Adalimumab Revenue by Type (2016-2021e) & (USD Million) Table 39. Global Adalimumab Revenue by Type (2021-2026) & (USD Million) Table 40. Global Adalimumab Price by Type (2016-2021e) & (USD/Unit) Table 41. Global Adalimumab Price by Type (2021-2026) & (USD/Unit) Table 42. Global Adalimumab Sales by Application (2016-2021e) & (K Units) Table 43. Global Adalimumab Sales by Application (2021-2026) & (K Units) Table 44. Global Adalimumab Revenue by Application (2016-2021e) & (USD Million) Table 45. Global Adalimumab Revenue by Application (2021-2026) & (USD Million) Table 46. Global Adalimumab Price by Application (2016-2021e) & (USD/Unit) Table 47. Global Adalimumab Price by Application (2021-2026) & (USD/Unit) Table 48. North America Adalimumab Sales by Country (2016-2021e) & (K Units) Table 49. North America Adalimumab Sales by Country (2021-2026) & (K Units) Table 50. North America Adalimumab Revenue by Country (2016-2021e) & (USD Million) Table 51. North America Adalimumab Revenue by Country (2021-2026) & (USD Million) Table 52. North America Adalimumab Sales by Type (2016-2021e) & (K Units) Table 53. North America Adalimumab Sales by Type (2021-2026) & (K Units) Table 54. North America Adalimumab Sales by Application (2016-2021e) & (K Units) Table 55. North America Adalimumab Sales by Application (2021-2026) & (K Units) Table 56. Europe Adalimumab Sales by Country (2016-2021e) & (K Units) Table 57. Europe Adalimumab Sales by Country (2021-2026) & (K Units) Table 58. Europe Adalimumab Revenue by Country (2016-2021e) & (USD Million) Table 59. Europe Adalimumab Revenue by Country (2021-2026) & (USD Million) Table 60. Europe Adalimumab Sales by Type (2016-2021e) & (K Units) Table 61. Europe Adalimumab Sales by Type (2021-2026) & (K Units) Table 62. Europe Adalimumab Sales by Application (2016-2021e) & (K Units) Table 63. Europe Adalimumab Sales by Application (2021-2026) & (K Units) Table 64. Asia-Pacific Adalimumab Sales by Region (2016-2021e) & (K Units) Table 65. Asia-Pacific Adalimumab Sales by Region (2021-2026) & (K Units) Table 66. Asia-Pacific Adalimumab Revenue by Region (2016-2021e) & (USD Million) Table 67. Asia-Pacific Adalimumab Revenue by Region (2021-2026) & (USD Million) Table 68. Asia-Pacific Adalimumab Sales by Type (2016-2021e) & (K Units) Table 69. Asia-Pacific Adalimumab Sales by Type (2021-2026) & (K Units) Table 70. Asia-Pacific Adalimumab Sales by Application (2016-2021e) & (K Units) Table 71. Asia-Pacific Adalimumab Sales by Application (2021-2026) & (K Units) Table 72. South America Adalimumab Sales by Country (2016-2021e) & (K Units) Table 73. South America Adalimumab Sales by Country (2021-2026) & (K Units) Table 74. South America Adalimumab Revenue by Country (2016-2021e) & (USD Million) Table 75. South America Adalimumab Revenue by Country (2021-2026) & (USD Million) Table 76. South America Adalimumab Sales by Type (2016-2021e) & (K Units) Table 77. South America Adalimumab Sales by Type (2021-2026) & (K Units) Table 78. South America Adalimumab Sales by Application (2016-2021e) & (K Units) Table 79. South America Adalimumab Sales by Application (2021-2026) & (K Units) Table 80. Middle East & Africa Adalimumab Sales by Country (2016-2021e) & (K Units) Table 81. Middle East & Africa Adalimumab Sales by Country (2021-2026) & (K Units) Table 82. Middle East & Africa Adalimumab Revenue by Country (2016-2021e) & (USD Million) Table 83. Middle East & Africa Adalimumab Revenue by Country (2021-2026) & (USD Million) Table 84. Middle East & Africa Adalimumab Sales by Type (2016-2021e) & (K Units) Table 85. Middle East & Africa Adalimumab Sales by Type (2021-2026) & (K Units) Table 86. Middle East & Africa Adalimumab Sales by Application (2016-2021e) & (K Units) Table 87. Middle East & Africa Adalimumab Sales by Application (2021-2026) & (K Units) Table 88. Direct Channel Pros & Cons Table 89. Indirect Channel Pros & Cons Table 90. Adalimumab Typical Distributors Table 91. Adalimumab Typical Customers List of Figures Figure 1. Adalimumab Picture Figure 2. Global Adalimumab Sales Market Share by Type in 2020 Figure 3. Adalimumab Figure 4. Adalimumab Biosimilar Figure 5. Global Adalimumab Sales Market Share by Application in 2020 Figure 6. Adults Figure 7. Children Figure 8. Global Adalimumab Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026 Figure 9. Global Adalimumab Market Size and Forecast (2016-2026) & (USD Million) Figure 10. United States Adalimumab Revenue and Growth Rate (2016-2026) & (USD Million) Figure 11. Canada Adalimumab Revenue and Growth Rate (2016-2026) & (USD Million) Figure 12. Mexico Adalimumab Revenue and Growth Rate (2016-2026) & (USD Million) Figure 13. Germany Adalimumab Revenue and Growth Rate (2016-2026) & (USD Million) Figure 14. France Adalimumab Revenue and Growth Rate (2016-2026) & (USD Million) Figure 15. United Kingdom Adalimumab Revenue and Growth Rate (2016-2026) & (USD Million) Figure 16. Russia Adalimumab Revenue and Growth Rate (2016-2026) & (USD Million) Figure 17. Italy Adalimumab Revenue and Growth Rate (2016-2026) & (USD Million) Figure 18. China Adalimumab Revenue and Growth Rate (2016-2026) & (USD Million) Figure 19. Japan Adalimumab Revenue and Growth Rate (2016-2026) & (USD Million) Figure 20. Korea Adalimumab Revenue and Growth Rate (2016-2026) & (USD Million) Figure 21. India Adalimumab Revenue and Growth Rate (2016-2026) & (USD Million) Figure 22. Southeast Asia Adalimumab Revenue and Growth Rate (2016-2026) & (USD Million) Figure 23. Australia Adalimumab Revenue and Growth Rate (2016-2026) & (USD Million) Figure 24. Brazil Adalimumab Revenue and Growth Rate (2016-2026) & (USD Million) Figure 25. Egypt Adalimumab Revenue and Growth Rate (2016-2026) & (USD Million) Figure 26. Saudi Arabia Adalimumab Revenue and Growth Rate (2016-2026) & (USD Million) Figure 27. South Africa Adalimumab Revenue and Growth Rate (2016-2026) & (USD Million) Figure 28. Turkey Adalimumab Revenue and Growth Rate (2016-2026) & (USD Million) Figure 29. Global Adalimumab Sales (2016-2026) & (K Units) Figure 30. Global Adalimumab Production Capacity (2016-2026) & (K Units) Figure 31. Global Adalimumab Production Capacity by Geographic Region: 2020 VS 2021 Figure 32. Adalimumab Market Drivers Figure 33. Adalimumab Market Restraints Figure 34. Adalimumab Market Trends Figure 35. Global Adalimumab Sales Market Share by Manufacturer in 2020 Figure 36. Global Adalimumab Revenue Market Share by Manufacturer in 2020 Figure 37. Adalimumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3) Figure 38. Top 3 Adalimumab Manufacturer (Revenue) Market Share in 2020 Figure 39. Top 6 Adalimumab Manufacturer (Revenue) Market Share in 2020 Figure 40. Global Adalimumab Sales Market Share by Region (2016-2026) Figure 41. Global Adalimumab Revenue Market Share by Region (2016-2026) Figure 42. North America Adalimumab Revenue (2016-2026) & (USD Million) Figure 43. Europe Adalimumab Revenue (2016-2026) & (USD Million) Figure 44. Asia-Pacific Adalimumab Revenue (2016-2026) & (USD Million) Figure 45. South America Adalimumab Revenue (2016-2026) & (USD Million) Figure 46. Middle East & Africa Adalimumab Revenue (2016-2026) & (USD Million) Figure 47. Global Adalimumab Sales Market Share by Type (2016-2026) Figure 48. Global Adalimumab Revenue Market Share by Type (2016-2026) Figure 49. Global Adalimumab Price by Type (2016-2026) & (USD/Unit) Figure 50. Global Adalimumab Sales Market Share by Application (2016-2026) Figure 51. Global Adalimumab Revenue Market Share by Application (2016-2026) Figure 52. Global Adalimumab Price by Application (2016-2026) & (USD/Unit) Figure 53. North America Adalimumab Sales Market Share by Country (2016-2026) Figure 54. North America Adalimumab Revenue Market Share by Country (2016-2026) Figure 55. North America Adalimumab Sales Market Share by Type (2016-2026) Figure 56. North America Adalimumab Sales Market Share by Application (2016-2026) Figure 57. Europe Adalimumab Sales Market Share by Country (2016-2026) Figure 58. Europe Adalimumab Revenue Market Share by Country (2016-2026) Figure 59. Europe Adalimumab Sales Market Share by Type (2016-2026) Figure 60. Europe Adalimumab Sales Market Share by Application (2016-2026) Figure 61. Asia-Pacific Adalimumab Sales Market Share by Region (2016-2026) Figure 62. Asia-Pacific Adalimumab Revenue Market Share by Region (2016-2026) Figure 63. Asia-Pacific Adalimumab Sales Market Share by Region (2016-2026) Figure 64. Asia-Pacific Adalimumab Sales Market Share by Application (2016-2026) Figure 65. South America Adalimumab Sales Market Share by Country (2016-2026) Figure 66. South America Adalimumab Revenue Market Share by Country (2016-2026) Figure 67. South America Adalimumab Sales Market Share by Type (2016-2026) Figure 68. South America Adalimumab Sales Market Share by Application (2016-2026) Figure 69. Middle East & Africa Adalimumab Sales Market Share by Country (2016-2026) Figure 70. Middle East & Africa Adalimumab Revenue Market Share by Country (2016-2026) Figure 71. Middle East & Africa Adalimumab Sales Market Share by Type (2016-2026) Figure 72. Middle East & Africa Adalimumab Sales Market Share by Application (2016-2026) Figure 73. Sales Channel: Direct Channel vs Indirect Channel Figure 74. Methodology Figure 75. Research Process and Data Source

Qualitative Analysis covers:

  • Industry Status and Trends
  • Manufacturer/Company profiles, manufacturing base distribution, sales areas, product introduction, main business, market position and their competitors.
  • Product Development, Technology, Price, Cost, Manufacturing Process and Trends
  • Market segment by regions, types, applications and forecast
  • Market opportunities, potential, government policies and influence factors.
     

Quantitative Analysis covers:

  • Market size (value, sales/output, historical data and forecasts)
  • Sales/output/capacity, revenue, price, gross margin, market share, for top players. Through interviewing each manufacturers,  distributors, traders, dealers and buyers etc.
  • Cost structure, proportion, price trend, gross margin and trend, status and trend, for 10 years
  • Market size by types, regions, applications for 10 years
  • Market forecast based on the potential demand from downstream clients/buyers, government, influence factors and the total economic indication, maybe occur in following years.
     

Data Sources:

Methodology

 

Publisher: GlobalInfoResearch
Chat with us